Trials / Unknown
UnknownNCT00776568
Treatment of Refractory Angina Pectoris by Shock Wave Therapy
Extracorporeal Shock Wave Therapy (ESWT) for the Treatment of Refractory Angina Pectoris
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Universal Research Group · Network
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine that extracorporeal shock wave therapy (ESWT) is safe and effective for the treatment of refractory angina pectoris.
Detailed description
Patients with advanced CAD frequently have limited symptoms with recurrent angina, angina at low work thresholds, breathlessness, and other debilitating conditions. These patients have often been through several "re-do" coronary bypass procedures and multiple percutaneous coronary interventions. Surgical and interventional options for these patients typically have been exhausted or will result in only partial revascularization. Therefore, therapy remains limited to the use of multiple anti-anginal medications, reduced activity, exertion, and stress level, and significant alteration and limitation of lifestyle. The goal of this emerging approach is to therapeutically induce the growth and development of new vasculature in zones of severe ischemia in the myocardium, with the hope that new capillaries and arterioles generated will connect to remnant existing vasculature. These neovessels are viewed to act as collaterals, perfusing ischemic territories unapproachable by macro procedures such as PCI and/or CABG.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Extra-corporeal shockwave | Low intensity shock waves are applied as 300 shocks per visit for 09 visits. The treatment visit is carried at week 1, 5 and 9. |
| DRUG | Anti-hypertensive drugs | ACE inhibitors, Ca channel blockers, Beta blockers, Diuretics, Cholesterol lowering agents and/or other drugs used alone or in combination, as prescribed. |
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2009-08-01
- First posted
- 2008-10-21
- Last updated
- 2008-10-21
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT00776568. Inclusion in this directory is not an endorsement.